US › Healthcare

China Pharma Holdings Inc (CPHI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.18+3.51%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$983,536

Revenue YoY

-13.4%

Net profit

$-1.1M

Profit YoY

-45.5%

EPS

$-0.17

EPS estimate

$0.00

Net margin

-116.2%

Key statistics

Market cap

$45.0M

Forward P/E

1.6

P/B

1.21

Book value

$0.91

EPS (TTM)

$-0.54

52-week high

$8.10

52-week low

$0.50

50-day MA

$1.01

200-day MA

$1.06

Beta

1.15

Analyst view

with an average price target of $3.00.

Shareholding

Insiders

89.63%

Institutions

0.06%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for China Pharma Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.